Injectable Influenza Vaccine
SPE2DP24R0003 · DEPT OF DEFENSE
A BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING solicitation, with responses due 2024-10-23. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Influenza Vaccine Solicitation: SPE2DP24R0003 and AMENDMENT 0001. Offer Due Date/Local Time: 2024 OCTOBER 23 03:00 PM.
Comparable recent awards in BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| JACKSON LABORATORY | $3.0M | 1 | 2026-07-01 |
| BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE | $3.7M | n/a | 2026-06-26 |
| BANNER HEALTH | $30K | 1 | 2026-06-26 |
| LIFE TECHNOLOGIES CORPORATION | $51K | 1 | 2026-06-26 |
| ILLUMINA, INC. | $56K | 1 | 2026-06-22 |
Questions
What is solicitation SPE2DP24R0003?
Injectable Influenza Vaccine, issued by DEPT OF DEFENSE, under NAICS 325414 (BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING). Responses are due 2024-10-23.
What do similar contracts close for?
Comparable closed awards in this category ran from $30K to $3.7M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.